Reliance Life Sciences Private Limited recalls Bortezomib for Injection 3.5mg/Vial
- Recalling company
- Reliance Life Sciences Private Limited
- Product
- Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
- Reason
- Lack of Sterility Assurance
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 24, 2026
- Reported
- Jul 15, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 11,400 vials
- Lot / codes
- Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028
- Company location
- Navi Mumbai, N/A
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0673-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0673-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.